BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011;46:421-431. [PMID: 21331765 DOI: 10.1007/s00535-011-0379-9] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Pirkola L, Laatikainen R, Loponen J, Hongisto SM, Hillilä M, Nuora A, Yang B, Linderborg KM, Freese R. Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill® study. World J Gastroenterol 2018; 24(11): 1259-1268 [PMID: 29568206 DOI: 10.3748/wjg.v24.i11.1259] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50:11-30. [PMID: 25500976 DOI: 10.1007/s00535-014-1017-0] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 9.8] [Reference Citation Analysis]
3 Zhou SY, Gillilland M, Wu X, Leelasinjaroen P, Zhang G, Zhou H, Ye B, Lu Y, Owyang C. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest. 2018;128:267-280. [PMID: 29202473 DOI: 10.1172/jci92390] [Cited by in Crossref: 68] [Cited by in F6Publishing: 30] [Article Influence: 13.6] [Reference Citation Analysis]
4 Berg LK, Goll R, Fagerli E, Ludviksen JK, Fure H, Moen OS, Sørbye SW, Mollnes TE, Florholmen J. Intestinal inflammatory profile shows increase in a diversity of biomarkers in irritable bowel syndrome. Scand J Gastroenterol 2020;55:537-42. [PMID: 32329383 DOI: 10.1080/00365521.2020.1754455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F. Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 2021;6:150052. [PMID: 34138761 DOI: 10.1172/jci.insight.150052] [Reference Citation Analysis]
6 Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Front Cell Infect Microbiol 2020;10:468. [PMID: 33014892 DOI: 10.3389/fcimb.2020.00468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
7 Picard E, Carvalho FA, Agosti F, Bourinet E, Ardid D, Eschalier A, Daulhac L, Mallet C. Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation. Br J Pharmacol 2019;176:950-63. [PMID: 30714145 DOI: 10.1111/bph.14608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
8 Cao YN, Feng LJ, Liu YY, Jiang K, Zhang MJ, Gu YX, Wang BM, Gao J, Wang ZL, Wang YM. Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome. World J Gastroenterol 2018; 24(3): 338-350 [PMID: 29391756 DOI: 10.3748/wjg.v24.i3.338] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
9 Jones MP, Chey WD, Singh S, Gong H, Shringarpure R, Hoe N, Chuang E, Talley NJ. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther 2014;39:426-37. [DOI: 10.1111/apt.12608] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
10 Lind R, Berstad A, Hatlebakk J, Valeur J. Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact Scale. Clin Exp Gastroenterol. 2013;6:101-107. [PMID: 23869173 DOI: 10.2147/ceg.s45760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
11 Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosén A. Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.Front Immunol. 2018;9:229. [PMID: 29497420 DOI: 10.3389/fimmu.2018.00229] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
12 Chiaffarino F, Cipriani S, Ricci E, Mauri PA, Esposito G, Barretta M, Vercellini P, Parazzini F. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis. Arch Gynecol Obstet 2021;303:17-25. [PMID: 32949284 DOI: 10.1007/s00404-020-05797-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Niu XL, Zhou YH, Sun SY, Zhuang L. Influence of Fagopyrum cymosum tablets on immune inflammation and visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2013; 21(32): 3543-3549 [DOI: 10.11569/wcjd.v21.i32.3543] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Glickman-simon R, Wallace J. Acupuncture for Knee Osteoarthritis, Chasteberry for Premenstrual Syndrome, Probiotics for Irritable Bowel Syndrome, Yoga for Hypertension, and Trigger Point Dry Needling for Plantar Fasciitis. EXPLORE 2015;11:157-61. [DOI: 10.1016/j.explore.2014.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therap Adv Gastroenterol 2020;13:1756284819897531. [PMID: 32047534 DOI: 10.1177/1756284819897531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Roisinblit KC. Irritable Bowel Syndrome in Women. Journal of Midwifery & Women's Health 2013;58:15-24. [DOI: 10.1111/j.1542-2011.2012.00200.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Li P, Shen M, Lou GC, Chen YW, Wu WQ. Meta-analysis of mesalazine for irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2015; 23(30): 4911-4918 [DOI: 10.11569/wcjd.v23.i30.4911] [Reference Citation Analysis]
18 Zhang Y, Wu XX, Li S, Wu JF, Han S, Lin ZJ, Ding SZ, Gong WJ. Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13741. [PMID: 31613423 DOI: 10.1111/nmo.13741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 García-Carrasco M, Mendoza-Pinto C, Munguía-Realpozo P, Méndez-Valderrabano F, Méndez Martínez S, Etchegaray Morales I, Montiel-Jarquín Á, López-Colombo A, Schmulson M. Functional gastrointestinal disorders in women with systemic lupus erythematosus: A case-control study. Neurogastroenterol Motil 2019;31:e13693. [PMID: 31373090 DOI: 10.1111/nmo.13693] [Reference Citation Analysis]
20 Walker MM, Keely SJ, Scott RJ, Talley NJ. Genetics, Mucosal Inflammation and the Environment in Post-Infectious Chronic Gut Syndromes. Am J Gastroenterol Suppl 2016;3:46-51. [DOI: 10.1038/ajgsup.2016.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, Umeh G, Miranda PM, Pigrau Pastor M, Sidani S, Pinto-Sanchez MI, Philip V, McLean PG, Hagelsieb MG, Surette MG, Bergonzelli GE, Verdu EF, Britz-McKibbin P, Neufeld JD, Collins SM, Bercik P. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9. [PMID: 28251905 DOI: 10.1126/scitranslmed.aaf6397] [Cited by in Crossref: 197] [Cited by in F6Publishing: 172] [Article Influence: 39.4] [Reference Citation Analysis]
22 Xu D, Gao J, Gillilland M, Wu X, Song I, Kao JY, Owyang C. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology. 2014;146:484-96.e4. [PMID: 24161699 DOI: 10.1053/j.gastro.2013.10.026] [Cited by in Crossref: 146] [Cited by in F6Publishing: 135] [Article Influence: 16.2] [Reference Citation Analysis]
23 Matricon J, Muller E, Accarie A, Meleine M, Etienne M, Voilley N, Busserolles J, Eschalier A, Lazdunski M, Bourdu S. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome. Neurogastroenterol Motil. 2013;25:e740-e754. [PMID: 23902154 DOI: 10.1111/nmo.12199] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
24 Wen Y, Li J, Long Q, Yue C, He B, Tang X. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials. International Journal of Surgery 2020;79:111-9. [DOI: 10.1016/j.ijsu.2020.04.063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
25 Gracie DJ, Ford AC. IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol. 2015;8:101-109. [PMID: 25733921 DOI: 10.2147/ceg.s58153] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 3.1] [Reference Citation Analysis]
26 Lee EH, Yang HR, Lee HS. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil 2016;22:459-69. [PMID: 27053514 DOI: 10.5056/jnm15174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
27 Fukuba N, Ishihara S, Tada Y, Oshima N, Moriyama I, Yuki T, Kawashima K, Kushiyama Y, Fujishiro H, Kinoshita Y. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study. Scand J Gastroenterol. 2014;49:674-680. [PMID: 24646420 DOI: 10.3109/00365521.2014.898084] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
28 Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11:497-505. [PMID: 24751910 DOI: 10.1038/nrgastro.2014.40] [Cited by in Crossref: 183] [Cited by in F6Publishing: 169] [Article Influence: 22.9] [Reference Citation Analysis]
29 Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother. 2014;10:1611-1621. [PMID: 24732667 DOI: 10.4161/hv.28549] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
30 Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, Garcia-Perez JE, Van Oudenhove L, Van Ranst M, Verhaegen J, Liston A, Boeckxstaens G. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65:1279-1288. [PMID: 26071133 DOI: 10.1136/gutjnl-2015-309460] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
31 Wu C, Chang W, Chang Y, Li C, Chuang C. The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study. Int J Colorectal Dis 2015;30:907-12. [DOI: 10.1007/s00384-015-2218-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
32 Niu H, Xiao J. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. International Journal of Surgery 2020;75:116-27. [DOI: 10.1016/j.ijsu.2020.01.142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
33 Itomi Y, Kawamura T, Tsukimi Y. Specific alteration of rhythm in temperature-stressed rats possess features of abdominal pain in IBS patients. Journal of Pharmacological Sciences 2015;129:26-30. [DOI: 10.1016/j.jphs.2015.07.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
34 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
35 Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4:632-642. [PMID: 31122802 DOI: 10.1016/s2468-1253(19)30089-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 16.0] [Reference Citation Analysis]
36 Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: contemporary nutrition management strategies. JPEN J Parenter Enteral Nutr. 2014;38:781-799. [PMID: 25085503 DOI: 10.1177/0148607114545329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
37 Camilleri M, Halawi H, Oduyebo I. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we? Expert Rev Gastroenterol Hepatol 2017;11:303-16. [PMID: 28128666 DOI: 10.1080/17474124.2017.1288096] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
38 Fujikawa Y, Tominaga K, Tanaka F, Tanigawa T, Watanabe T, Fujiwara Y, Arakawa T. Enteric glial cells are associated with stress-induced colonic hyper-contraction in maternally separated rats. Neurogastroenterol Motil. 2015;27:1010-1023. [PMID: 25960044 DOI: 10.1111/nmo.12577] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
39 Norlin A, Walter S, Icenhour A, Keita ÅV, Elsenbruch S, Bednarska O, Jones MP, Simon R, Engström M. Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesocorticolimbic connectivity. Brain, Behavior, and Immunity 2021;92:211-20. [DOI: 10.1016/j.bbi.2020.11.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Guo J, Pei L, Chen L, Chen H, Gu D, Peng Y, Sun J. Bidirectional association between irritable bowel syndrome and restless legs syndrome: a systematic review and meta-analysis. Sleep Med 2021;77:104-11. [PMID: 33348297 DOI: 10.1016/j.sleep.2020.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Singh M, Singh V, Schurman JV, Colombo JM, Friesen CA. The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Sci Rep 2020;10:11988. [PMID: 32686762 DOI: 10.1038/s41598-020-68961-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
42 von Arnim U, Wex T, Ganzert C, Schulz C, Malfertheiner P. Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome. Clin Exp Gastroenterol 2016;9:97-103. [PMID: 27147826 DOI: 10.2147/CEG.S97701] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
43 Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest. 2015;45:1350-1359. [PMID: 26444549 DOI: 10.1111/eci.12548] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
44 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
45 Karatay E, Utku ÖG. Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome. Turk J Gastroenterol 2020;31:113-9. [PMID: 32141819 DOI: 10.5152/tjg.2020.19751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:359-365.e1. [PMID: 23246645 DOI: 10.1016/j.cgh.2012.11.033] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
47 Shen TC, Lin CL, Wei CC, Chen CH, Tu CY, Hsia TC, Shih CM, Hsu WH, Sung FC, Kao CH. Bidirectional Association between Asthma and Irritable Bowel Syndrome: Two Population-Based Retrospective Cohort Studies. PLoS One. 2016;11:e0153911. [PMID: 27093172 DOI: 10.1371/journal.pone.0153911] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
48 Münch A, Mihaly E, Nagy F, Madisch A, Kupčinskas J, Miehlke S, Bohr J, Bouma G, Guardiola J, Belloc B, Shi C, Aust D, Mohrbacher R, Greinwald R, Munck LK. Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial. United European Gastroenterol J 2021. [PMID: 34414678 DOI: 10.1002/ueg2.12131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Wilcz-villega EM, Mcclean S, O’sullivan MA. Mast Cell Tryptase Reduces Junctional Adhesion Molecule-A (JAM-A) Expression in Intestinal Epithelial Cells: Implications for the Mechanisms of Barrier Dysfunction in Irritable Bowel Syndrome. American Journal of Gastroenterology 2013;108:1140-51. [DOI: 10.1038/ajg.2013.92] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 7.6] [Reference Citation Analysis]
50 Lee EH, Yang HR, Lee HS. Quantitative Analysis of Distribution of the Gastrointestinal Tract Eosinophils in Childhood Functional Abdominal Pain Disorders. J Neurogastroenterol Motil 2018;24:614-27. [PMID: 30180307 DOI: 10.5056/jnm18050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kramer NE, Cosgrove VE, Dunlap K, Subramaniapillai M, Mcintyre RS, Suppes T. A clinical model for identifying an inflammatory phenotype in mood disorders. Journal of Psychiatric Research 2019;113:148-58. [DOI: 10.1016/j.jpsychires.2019.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019;114:429-436. [PMID: 30839392 DOI: 10.1038/s41395-018-0377-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
53 Zhao Q, Yang WR, Wang XH, Li GQ, Xu LQ, Cui X, Liu Y, Zuo XL. Clostridium butyricum alleviates intestinal low-grade inflammation in TNBS-induced irritable bowel syndrome in mice by regulating functional status of lamina propria dendritic cells. World J Gastroenterol 2019; 25(36): 5469-5482 [PMID: 31576093 DOI: 10.3748/wjg.v25.i36.5469] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
54 Holtmann G, Shah A, Morrison M. Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview. Dig Dis 2017;35 Suppl 1:5-13. [PMID: 29421808 DOI: 10.1159/000485409] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
55 Shulman RJ, Jarrett ME, Cain KC, Broussard EK, Heitkemper MM. Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome. J Gastroenterol 2014;49:1467-76. [PMID: 24435814 DOI: 10.1007/s00535-013-0919-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
56 Jin Y, Ren X, Li G, Li Y, Zhang L, Wang H, Qian W, Hou X. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota. J Gastroenterol Hepatol 2018;33:443-52. [PMID: 28573746 DOI: 10.1111/jgh.13841] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
57 Yen C, Muo C, Lin M, Chang S, Chang Y, Kao C. A nationwide population cohort study: Irritable bowel syndrome is a risk factor of osteoporosis. European Journal of Internal Medicine 2014;25:87-91. [DOI: 10.1016/j.ejim.2013.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
58 Singh R, Salem A, Nanavati J, Mullin GE. The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review. Gastroenterol Clin North Am 2018;47:107-37. [PMID: 29413008 DOI: 10.1016/j.gtc.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
59 Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, Verschueren S, Houben E, Salim Rasoel S, Tόth J, Holvoet L, Farré R, Van Oudenhove L, Boeckxstaens G, Verbeke K, Tack J. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 2014;63:1293-9. [PMID: 24153250 DOI: 10.1136/gutjnl-2013-305690] [Cited by in Crossref: 246] [Cited by in F6Publishing: 233] [Article Influence: 27.3] [Reference Citation Analysis]
60 Kumari MV, Amarasiri L, Rajindrajith S, Devanarayana NM. Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology? Expert Rev Gastroenterol Hepatol 2021;15:9-24. [PMID: 32909837 DOI: 10.1080/17474124.2020.1821652] [Reference Citation Analysis]
61 Tada Y, Ishihara S, Kawashima K, Fukuba N, Sonoyama H, Kusunoki R, Oka A, Mishima Y, Oshima N, Moriyama I, Yuki T, Ishikawa N, Araki A, Harada Y, Maruyama R, Kinoshita Y. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis. J Gastroenterol Hepatol 2016;31:1443-52. [PMID: 26676714 DOI: 10.1111/jgh.13268] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
62 Kamp EJ, Kane JS, Ford AC. Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2016;14:659-668.e1; quiz e54-55. [PMID: 26453949 DOI: 10.1016/j.cgh.2015.09.031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
63 Schomacker ML, Hansen KE, Ramlau-hansen CH, Forman A. Is endometriosis associated with irritable bowel syndrome? A cross-sectional study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2018;231:65-9. [DOI: 10.1016/j.ejogrb.2018.10.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
64 Yang CQ, Wei YY, Zhong CJ, Duan LP. Essential role of mast cells in the visceral hyperalgesia induced by T. spiralis infection and stress in rats. Mediators Inflamm. 2012;2012:294070. [PMID: 22529522 DOI: 10.1155/2012/294070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
65 De Ponti F. Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front Pharmacol. 2013;4:7. [PMID: 23378837 DOI: 10.3389/fphar.2013.00007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
66 Wilcz-Villega E, McClean S, O’Sullivan M. Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS. Neurogastroenterol Motil. 2014;26:316-325. [PMID: 24286617 DOI: 10.1111/nmo.12262] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
67 Cash BD, Epstein MS, Shah SM. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Dig Dis Sci. 2016;61:560-571. [PMID: 26319955 DOI: 10.1007/s10620-015-3858-7] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 11.1] [Reference Citation Analysis]
68 Peluso I, Raguzzini A, Serafini M. Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis. Mol Nutr Food Res 2013;57:784-801. [PMID: 23471810 DOI: 10.1002/mnfr.201200721] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
69 Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. The Lancet Gastroenterology & Hepatology 2016;1:133-46. [DOI: 10.1016/s2468-1253(16)30023-1] [Cited by in Crossref: 171] [Cited by in F6Publishing: 75] [Article Influence: 28.5] [Reference Citation Analysis]
70 Seong G, Lee S, Min YW, Jang YS, Park SY, Kim CH, Lee C, Hong SN, Chang DK. Effect of a Synbiotic Containing Lactobacillus paracasei and Opuntia humifusa on a Murine Model of Irritable Bowel Syndrome. Nutrients 2020;12:E3205. [PMID: 33092151 DOI: 10.3390/nu12103205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382-391. [PMID: 24961872 DOI: 10.1111/apt.12846] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
72 Shutkever O, Gracie DJ, Young C, Wood HM, Taylor M, John Hamlin P, Ford AC, Quirke P. No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2018;24:1597-605. [DOI: 10.1093/ibd/izy052] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
73 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
74 Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. The Lancet 2020;396:1689-702. [DOI: 10.1016/s0140-6736(20)30469-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 14.5] [Reference Citation Analysis]
75 Afrin LB. Mast cell activation disease and the modern epidemic of chronic inflammatory disease. Translational Research 2016;174:33-59. [DOI: 10.1016/j.trsl.2016.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
76 Park J, Choi TJ, Kang KS, Choi SH. The Interrelationships between Intestinal Permeability and Phlegm Syndrome and Therapeutic Potential of Some Medicinal Herbs. Biomolecules 2021;11:284. [PMID: 33671865 DOI: 10.3390/biom11020284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Ishihara S, Yashima K, Kushiyama Y, Izumi A, Kawashima K, Fujishiro H, Kojo H, Komazawa Y, Hamamoto T, Yamamoto T. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy. J Gastroenterol. 2012;47:1084-1090. [PMID: 22460220 DOI: 10.1007/s00535-012-0573-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
78 Dolatabadi F, Abdolghaffari AH, Farzaei MH, Baeeri M, Ziarani FS, Eslami M, Abdollahi M, Rahimi R. The Protective Effect of Melissa officinalis L. in Visceral Hypersensitivity in Rat Using 2 Models of Acid-induced Colitis and Stress-induced Irritable Bowel Syndrome: A Possible Role of Nitric Oxide Pathway. J Neurogastroenterol Motil 2018;24:490-501. [PMID: 29879761 DOI: 10.5056/jnm17035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
79 Ford AC, Talley NJ, Walker MM, Jones MP. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: Case-control study of 23471 primary care patients. Aliment Pharmacol Ther. 2014;40:827-834. [PMID: 25131320 DOI: 10.1111/apt.12903] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
80 Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. World J Gastroenterol 2018; 24(17): 1888-1900 [PMID: 29740204 DOI: 10.3748/wjg.v24.i17.1888] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
81 Yang B, Zhou X, Lan C. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome. BMC Gastroenterol. 2015;15:43. [PMID: 25886744 DOI: 10.1186/s12876-015-0272-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
82 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
83 Mansueto P, D’Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol 2015; 21(23): 7089-7109 [PMID: 26109796 DOI: 10.3748/wjg.v21.i23.7089] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
84 Li P, Shen M, Lou GC, Chen YW, Wu WQ. Meta-analysis of mesalazine for irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2015; 23(30): 4911-4918 [DOI: 10.11569/wcjd.v23.i30.4911.] [Reference Citation Analysis]
85 Seong G, Lee S, Min YW, Jang YS, Kim HS, Kim EJ, Park SY, Kim CH, Chang DK. Effect of Heat-killed Lactobacillus casei DKGF7 on a Rat Model of Irritable Bowel Syndrome. Nutrients 2021;13:568. [PMID: 33572194 DOI: 10.3390/nu13020568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Mönnikes H, Schwan T, van Rensburg C, Straszak A, Theek C, Lühmann R, Sander P, Tholen A. Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial. BMC Gastroenterol 2013;13:145. [PMID: 24083350 DOI: 10.1186/1471-230X-13-145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
87 Jones J, Lembo A, Heidelbaugh J, Kuritzky L, Lacy B. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Curr Med Res Opin 2021;37:567-78. [PMID: 33566707 DOI: 10.1080/03007995.2021.1888705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Hilmi I, Hartono JL, Pailoor J, Mahadeva S, Goh KL. Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea. BMC Gastroenterol 2013;13:80. [PMID: 23651739 DOI: 10.1186/1471-230X-13-80] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
89 Xiong F, Xiong M, Ma Z, Huang S, Li A, Liu S. Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study. Gastroenterol Res Pract. 2016;2016:3059201. [PMID: 27493660 DOI: 10.1155/2016/3059201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
90 Kim JH, Lin E, Pimentel M. Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017;23:20-6. [PMID: 27817184 DOI: 10.5056/jnm16135] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
91 Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1547-61; quiz 1546, 1562. [PMID: 25070051 DOI: 10.1038/ajg.2014.202] [Cited by in Crossref: 413] [Cited by in F6Publishing: 324] [Article Influence: 51.6] [Reference Citation Analysis]
92 Theodorou V, Ait Belgnaoui A, Agostini S, Eutamene H. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes. 2014;5:430-436. [PMID: 25184834 DOI: 10.4161/gmic.29796] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
93 Seo H, Park SH, Byeon JS, Woo CG, Hong SM, Chang K, So H, Kwak M, Kim WS, Lee JM, Yang DH, Kim KJ, Ye BD, Myung SJ, Yang SK. Chronic intractable diarrhea caused by gastrointestinal mastocytosis. Intest Res 2016;14:280-4. [PMID: 27433151 DOI: 10.5217/ir.2016.14.3.280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Sirri L, Grandi S, Tossani E. Smoking in Irritable Bowel Syndrome: A Systematic Review. Journal of Dual Diagnosis 2017;13:184-200. [DOI: 10.1080/15504263.2017.1322226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
95 Talley NJ, Fodor AA. Bugs, Stool, and the Irritable Bowel Syndrome: Too Much Is as Bad as Too Little? Gastroenterology 2011;141:1555-9. [DOI: 10.1053/j.gastro.2011.09.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
96 Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita ÅV, Pardon N, Santos J, Söderholm JD, Tack J, Farré R. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014;63:262-71. [PMID: 23474421 DOI: 10.1136/gutjnl-2012-303857] [Cited by in Crossref: 213] [Cited by in F6Publishing: 190] [Article Influence: 23.7] [Reference Citation Analysis]
97 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
98 Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014;49:1193-1205. [PMID: 24845149 DOI: 10.1007/s00535-014-0966-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
99 Vázquez-Frias R, Gutiérrez-Reyes G, Urbán-Reyes M, Velázquez-Guadarrama N, Fortoul-van der Goes TI, Reyes-López A, Consuelo-Sánchez A. Proinflammatory and anti-inflammatory cytokine profile in pediatric patients with irritable bowel syndrome. Rev Gastroenterol Mex 2015;80:6-12. [PMID: 25697785 DOI: 10.1016/j.rgmx.2014.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
100 Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Sim J, Jang KS. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea. Scand J Gastroenterol. 2014;49:43-51. [PMID: 24256141 DOI: 10.3109/00365521.2013.857712] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
101 Kodani M, Fukui H, Tomita T, Oshima T, Watari J, Miwa H. Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS‑induced colitis. Mol Med Rep 2018;17:8167-72. [PMID: 29693127 DOI: 10.3892/mmr.2018.8926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
102 Li C, Shuai Y, Zhou X, Chen H. Association between Helicobacter pylori infection and irritable bowel syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22975. [PMID: 33327230 DOI: 10.1097/MD.0000000000022975] [Reference Citation Analysis]
103 Bradley S, Alderson S, Ford AC, Foy R. General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study. Fam Pract 2018;35:74-9. [PMID: 28985313 DOI: 10.1093/fampra/cmx053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
104 Rossi G, Gioacchini G, Pengo G, Suchodolski JS, Jergens AE, Allenspach K, Gavazza A, Scarpona S, Berardi S, Galosi L, Bassotti G, Cerquetella M. Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes. Neurogastroenterol Motil 2020;32:e13717. [PMID: 31495983 DOI: 10.1111/nmo.13717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
105 Seyedmirzaee S, Hayatbakhsh MM, Ahmadi B, Baniasadi N, Bagheri Rafsanjani AM, Nikpoor AR, Mohammadi M. Serum immune biomarkers in irritable bowel syndrome. Clin Res Hepatol Gastroenterol. 2016;40:631-637. [PMID: 26850360 DOI: 10.1016/j.clinre.2015.12.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
106 Afrin LB. A new era for an old cell: heightened appreciation of mast cell disease emerges. Translational Research 2016;174:1-4. [DOI: 10.1016/j.trsl.2016.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
107 König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer RJ. Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol 2016;7:e196. [PMID: 27763627 DOI: 10.1038/ctg.2016.54] [Cited by in Crossref: 318] [Cited by in F6Publishing: 299] [Article Influence: 53.0] [Reference Citation Analysis]
108 Robles-Medranda C, Oleas R, Valero M, Puga-Tejada M, Soria-Alcívar M, Ospina J, Alvarado-Escobar H, Muñoz-Jurado G, Baquerizo-Burgos J, Pitanga-Lukashok H. Confocal laser endomicroscopy detects colonic inflammation in patients with irritable bowel syndrome: a prospective study. Endosc Int Open 2020;8:E550-7. [PMID: 32258379 DOI: 10.1055/a-1119-6327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
109 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
110 Kane JS, Ford AC. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2016;10:431-42. [PMID: 26753693 DOI: 10.1586/17474124.2016.1140571] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
111 Rodríguez-Nogales A, Algieri F, Vezza T, Garrido-Mesa J, Molina-Tijeras JA, Rodríguez-Cabezas ME, Utrilla MP, Pischel I, Gálvez J. Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats. Nutrients 2019;11:E140. [PMID: 30634696 DOI: 10.3390/nu11010140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
112 Rawla P, Sunkara T, Raj JP. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome. Life Sciences 2018;212:176-81. [DOI: 10.1016/j.lfs.2018.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
113 Li Y, Yang T, Yao Q, Li S, Fang E, Li Y, Liu C, Li W. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like rats. Neurogastroenterology & Motility 2019;31:e13556. [DOI: 10.1111/nmo.13556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
114 Gracie DJ, Williams CJ, Sood R, Mumtaz S, Bholah MH, Hamlin PJ, Ford AC. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2017;15:376-384.e5. [PMID: 27189912 DOI: 10.1016/j.cgh.2016.05.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
115 Eady SL, Wallace AJ, Hedderley DI, Bentley-hewitt KL, Butts CA. The Effects on Immune Function and Digestive Health of Consuming the Skin and Flesh of Zespri® SunGold Kiwifruit (Actinidia Chinensis var. Chinensis ‘Zesy002’) in Healthy and IBS-Constipated Individuals. Nutrients 2020;12:1453. [DOI: 10.3390/nu12051453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Johnson AC, Greenwood-Van Meerveld B. The Pharmacology of Visceral Pain. Adv Pharmacol 2016;75:273-301. [PMID: 26920016 DOI: 10.1016/bs.apha.2015.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
117 Corsetti M, Van Oudenhove L, Tack J. The quest for biomarkers in IBS-where should it lead us? Neurogastroenterol Motil 2014;26:1669-76. [DOI: 10.1111/nmo.12475] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
118 Rosette C, Buendia-laysa F, Patkar S, Moro L, Celasco G, Bozzella R, Ajani M, Gerloni M. Anti-inflammatory and immunomodulatory activities of rifamycin SV. International Journal of Antimicrobial Agents 2013;42:182-6. [DOI: 10.1016/j.ijantimicag.2013.04.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]